Magnetic resonance imaging for tumor restaging after chemotherapy in retinoblastoma with optic nerve invasion.
CONCLUSION: MRI is a valuable tool for restaging of retinoblastoma and predicting residual optic nerve disease after neoadjuvant chemotherapy. Combined thickening and enhancement on MRI appeared to be a more reliable indicator of post-laminar invasion as compared to thickening or enhancement alone.
PMID: 30089224 [PubMed - as supplied by publisher]
Source: Ophthalmic Genetics - Category: Opthalmology Tags: Ophthalmic Genet Source Type: research
More News: Brain | Brain Cancers | Chemotherapy | Children | Eye Cancers | Eyes | Genetics | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Opthalmology | PET Scan | Retinoblastoma | Study